Armata Pharmaceuticals (ARMP) EBT: 2013-2018
Historic EBT for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$1.1 million.
- Armata Pharmaceuticals' EBT rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 63.16%. This contributed to the annual value of -$53.2 million for FY2024, which is 22.71% down from last year.
- Armata Pharmaceuticals' EBT amounted to -$1.1 million in Q4 2018, which was up 60.27% from -$2.8 million recorded in Q3 2018.
- Armata Pharmaceuticals' 5-year EBT high stood at -$779,000 for Q3 2017, and its period low was -$11.3 million during Q1 2014.
- In the last 3 years, Armata Pharmaceuticals' EBT had a median value of -$3.1 million in 2016 and averaged -$3.9 million.
- Per our database at Business Quant, Armata Pharmaceuticals' EBT slumped by 691.25% in 2014 and then soared by 76.61% in 2017.
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' EBT stood at -$2.6 million in 2014, then fell by 13.21% to -$2.9 million in 2015, then plummeted by 242.04% to -$10.1 million in 2016, then surged by 76.61% to -$2.4 million in 2017, then soared by 53.19% to -$1.1 million in 2018.
- Its EBT was -$1.1 million in Q4 2018, compared to -$2.8 million in Q3 2018 and -$9.7 million in Q2 2018.